March 02, 2018
Rose
Pear Therapeutics has inked a deal with pharma company Novartis to work together on the development of two digital therapeutics for multiple sclerosis and schizophrenia. It’s the first time a pharma company has made a development deal with a digital therapeutic, according to Pear.
from MobiHealthNews http://ift.tt/2FKYuwa
March 02, 2018
Rose
MobiHealthNews
No comments
Related Posts:
UnitedHealthcare adds Apple Watch to Motion employee wellness program- HIMSS acquires Healthbox to get in the innovation consulting game
- Artificial intelligence is getting the hype, now what are the applications?
- UnitedHealthcare, Fitbit, and Castlight share secrets to workplace wellness success
- IT leaders highlight big success with machine learning models
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment